Publications by authors named "Koichi Kitazume"

Claim this Profile
C
Case series of long-term responders to pralatrexate in peripheral T-cell lymphoma.
Naoto Tomita, Koichi Kitazume, Toshiki Kitajima, Hiroki Hayata, Shuku Sato

J Clin Exp Hematop· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidation with Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma.
Katsuhiro Miura, Hideki Tsujimura, Yasufumi Masaki, Masaki Iino, Jun Takizawa, Koichi Kitazume

Hematol Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pralatrexate for Prolonged Treatment of Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified, with Prophylactic Leucovorin.
Koichi Kitazume, Yuri Akagawa, Sachie Wada, Takayuki Suzuki, Akira Fujita

Case Rep Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disorders of childhood with fulminant leukocytosis and tumor lysis: a case report with autopsy findings.
Sachie Wada, Takayuki Suzuki, Koichi Kitazume, Akira Fujita, Seiichiro Shimizu

Int J Hematol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma.
Katsuhiro Miura, Jun Konishi, Takaaki Miyake, Masanori Makita, Atsuko Hojo, Koichi Kitazume

Oncologist· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Splenic rupture associated with aggressive conversion of indolent T-cell prolymphocytic leukemia].
Sachie Wada, Koichi Kitazume, Takayuki Suzuki, Akira Fujita, Seiichiro Shimizu

Rinsho Ketsueki· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Evaluation of prophylactic use of lamivudine in HBV-positive patients with malignant lymphoma undergoing chemotherapy].
Koichi Kitazume, Hiraku Mori, Takakazu Higuchi, Kenji Shimamoto, Naoto Tomita

Rinsho Ketsueki· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis